Galapagos NV
GLPG
#4540
Rank
$2.23 B
Marketcap
$33.88
Share price
-0.73%
Change (1 day)
47.30%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: $2.23 Billion USD

As of February 2026 Galapagos NV has a market cap of $2.23 Billion USD. This makes Galapagos NV the world's 4540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026$2.23 B2.57%
2025$2.17 B20.99%
2024$1.79 B-32.84%
2023$2.67 B-8.32%
2022$2.92 B-20.02%
2021$3.65 B-43.58%
2020$6.47 B-52.07%
2019$13.50 B169.16%
2018$5.01 B4.51%
2017$4.80 B61.16%
2016$2.97 B20.89%
2015$2.46 B331.92%
2014$0.57 B-8.94%
2013$0.62 B10.91%
2012$0.56 B58.44%
2011$0.35 B-16.16%
2010$0.42 B66.9%
2009$0.25 B148.04%
2008$0.10 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Galapagos NV was reported to be:

$2.23 Billion USD
by Nasdaq info icon info icon
$2.23 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
$547.51 B 24,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$190.23 B 8,420.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$394.14 B 17,554.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$114.25 B 5,017.59%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$275.43 B 12,236.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$287.63 B 12,783.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$104.28 B 4,571.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
$96.21 M-95.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$39.09 B 1,651.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel